• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心肌梗死急性期患者的肠吸附疗法应用]

[The use of enterosorption in patients in the acute period of a myocardial infarct].

作者信息

Parkhomenko A N, Bartashevich L N, Popov E R

出版信息

Lik Sprava. 1992 Jan(1):55-7.

PMID:1364608
Abstract

The authors studied the clinical course of myocardial infarction during the acute period, the central and peripheral hemodynamics, immunological reactivity, dynamic electrocardiography by the Holter method in 107 patients with macrofocal and transmural myocardial infarction. It is concluded that it is rational include into the complex treatment of this condition the silicic enterosorbent "Polysorba". The authors recommend to begin polysorba treatment from the first day of onset of the disease especially in the presence of clinical signs of acute circulatory insufficiency. It is suggested to increase the bioavailability and bioassimilability of medicinal agents using the enterosorbent.

摘要

作者对107例大面积透壁性心肌梗死患者在急性期的心肌梗死临床病程、中心和外周血流动力学、免疫反应性以及采用动态心电图监测仪(Holter)方法进行的动态心电图进行了研究。得出结论,将硅酸肠道吸附剂“聚烯吡酮”纳入这种疾病的综合治疗是合理的。作者建议从疾病发作的第一天开始进行聚烯吡酮治疗,尤其是在存在急性循环功能不全临床体征的情况下。建议使用肠道吸附剂提高药物的生物利用度和生物可同化性。

相似文献

1
[The use of enterosorption in patients in the acute period of a myocardial infarct].[心肌梗死急性期患者的肠吸附疗法应用]
Lik Sprava. 1992 Jan(1):55-7.
2
[The joint use of plasmosorption and enterosorption in the combined treatment of patients in the acute period of a myocardial infarct].[血浆吸附与肠吸附联合应用于心肌梗死急性期患者的综合治疗]
Ter Arkh. 1995;67(6):11-4.
3
[Enterosorbent SKN in the combined rehabilitative treatment of patients who have had a myocardial infarct].[肠道吸附剂SKN在心肌梗死患者综合康复治疗中的应用]
Vrach Delo. 1991 Sep(9):87-9.
4
[A clinical assessment of the detoxifying effect of enterosorption in treating tuberculosis of the respiratory organs in children].[肠道吸附法对儿童呼吸道结核病解毒作用的临床评估]
Lik Sprava. 1998 Aug(6):62-4.
5
[The efficacy of enterosorption and a combination of antioxidants in schizophrenics].
Lik Sprava. 1998 Jun(4):122-4.
6
[Hemodynamic disorders in the acute period of myocardial infarct according to the radiocardiographic data].[根据放射心电图数据看心肌梗死急性期的血流动力学紊乱]
Kardiologiia. 1979 Jan;19(1):37-42.
7
[The effect of transcardiac galvanization on the size of the necrotic mass and on the central hemodynamic indices in patients with an acute myocardial infarct].[经心腔电刺激对急性心肌梗死患者坏死灶大小及中心血流动力学指标的影响]
Ter Arkh. 1994;66(8):19-21.
8
[The clinical efficacy of Vuglesorb enterosorbent in diabetic patients].[Vuglesorb肠道吸附剂对糖尿病患者的临床疗效]
Lik Sprava. 1993 Oct-Dec(10-12):102-4.
9
[The effect of the SKN charcoal enterosorbent on the clinico-laboratory indices of patients with chronic circulatory failure].
Lik Sprava. 1996 Jul-Sep(7-9):106-9.
10
[The clinical efficacy of the enterosorbent polifepan in the combined therapy of patients with infection-dependent bronchial asthma].[肠吸附剂聚多卡醇在感染相关性支气管哮喘患者联合治疗中的临床疗效]
Ter Arkh. 1993;65(3):25-6.